Simple Summary Epithelial ovarian cancer is one of the most lethal cancers in women and is
typically diagnosed at an advanced-stage. Historically, primary tumor reductive surgery was …

Despite the improvement in overall survival for ovarian cancer (OC) patients, a fraction of
patients with advanced-stage disease fails to respond to primary therapy and relapses in …

Epithelial ovarian cancer (EOC) is the deadliest gynaecological malignancy and the eighth
most prevalent cancer in women, with an abysmal mortality rate of two million worldwide …

Objectives Accurate assessment of disease extent is required to select the best primary
treatment for advanced epithelial ovarian cancer patients. Estimation of tumour burden is …

Introduction: Ovarian cancer is the leading cause of death among gynecological
malignancies. Its usual clinical manifestation is at advanced stages, with nutritional …

Objectives To assess the prognostic value of human epididymis protein 4 (HE4) kinetics
during and after neoadjuvant chemotherapy (NACT) cycles compared with cancer antigen …

Background The modeled CA-125 elimination constant K (KELIM) is a potential marker of
tumor chemosensitivity in ovarian cancer patients treated with neoadjuvant chemotherapy …

Postoperative chylous ascites is a rare complication from operative trauma to the cisterna
chyli or lymphatic vessels in the retroperitoneum. In the present study, we aimed to identify …

Ovarian cancers are known to evade immunosurveillance and to orchestrate a suppressive
immune microenvironment. Here we examine the role of human epididymis protein 4 (HE4) …

Background: The chemotherapy response score (CRS) system is a reproducible prognostic
tool for patients receiving neoadjuvant chemotherapy (NACT) for tubo-ovarian high-grade …